Bluejay Diagnostics, Inc.
BJDX
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; aā¦ read more
Healthcare
Medical Devices
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.86
Price-7.46%
-$0.07
1Y
Price
Market Cap
$390.045k
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$0.00
-
1y CAGR-33.3%
3y CAGR-25.0%
5y CAGREarnings
-$6.903m
+11.2%
1y CAGR+8.9%
3y CAGR-30.7%
5y CAGREPS
-$16.32
+45.3%
1y CAGR+29.4%
3y CAGR-14.6%
5y CAGRBook Value
$4.181m
$5.599m
Assets$1.417m
Liabilities$100.520k
DebtDebt to Assets
1.8%
-
Debt to EBITDAFree Cash Flow
-$6.651m
+22.0%
1y CAGR+10.3%
3y CAGR-18.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company